Showing results (71-80 of 384) with videos related to
Sort By:
Pageof 39
The Journal of Antimicrobial Chemotherapy|April 9, 1998
Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effectF J Boswell, J M Andrews, R WiseChemotherapy|January 1, 1977
The activity of four antimicrobial agents. Including three nitroimidazole compounds, against Bacteroides spR Wise, J M Andrews, K A BedfordThe Journal of Antimicrobial Chemotherapy|November 1, 1987
Factors affecting the in-vitro activity of roxithromycinJ M Andrews, J P Ashby, R WiseAntimicrobial Agents and Chemotherapy|February 1, 1987
In vitro activity of CGP 31608, a new penemR Wise, J M Andrews, L J PiddockAntimicrobial Agents and Chemotherapy|April 1, 1983
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsR Wise, J M Andrews, L J EdwardsThe Journal of Antimicrobial Chemotherapy|September 1, 1989
The antibacterial activity of meropenem in combination with gentamicin or vancomycinR Wise, J P Ashby, J M AndrewsAntimicrobial Agents and Chemotherapy|March 1, 1980
UK31214, a new aminoglycoside and derivative of kanamycin BR Wise, J M Andrews, K A BedfordThe Journal of Antimicrobial Chemotherapy|September 1, 1991
Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditionsM A Cooper, J M Andrews, R WiseThe Journal of Antimicrobial Chemotherapy|March 1, 1997
Pharmacodynamic properties of faropenem demonstrated by studies of time-kill kinetics and postantibiotic effectF J Boswell, J M Andrews, R WiseThe Journal of Antimicrobial Chemotherapy|April 1, 1981
Cefoperazone and cefotiam--two new cephalosporins: an in-vitro comparisonR Wise, J M Andrews, K A BedfordPageof 39